MichaelJosephVidoMDPhD

PubMed

• The Broad Stroke of Hsp90 Inhibitors: Painting over the RAF Inhibitor Paradox.
  Vido MJ, Aplin AE> ;The Journal of investigative dermatology.
• The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma.
  Boregowda RK, Medina DJ, Markert E, Bryan MA, Chen W, Chen S, Rabkin A, Vido MJ, Gunderson SI, Chekmareva M, Foran DJ, Lasfar A, Goydos JS, Cohen-Solal KA> ;Oncotarget.
• BRAF Splice Variant Resistance to RAF Inhibitor Requires Enhanced MEK Association.
  Vido MJ, Le K, Hartsough EJ, Aplin AE> ;Cell reports.
• Role of serine 365 in BRAF V600E sensitivity to RAF inhibition.
  Vido MJ, Rock J, Aplin AE> ;Pigment cell & melanoma research. 2020-10-14
• Response and Resistance to Paradox-Breaking BRAF Inhibitor in Melanomas In Vivo and Ex Vivo.
  Hartsough EJ, Kugel CH, Vido MJ, Berger AC, Purwin TJ, Goldberg A, Davies MA, Schiewer MJ, Knudsen KE, Bollag G, Aplin AE> ;Molecular cancer therapeutics. 2017-11-13
• αC IN, αC OUT-that's what it's all about.
  Edward J. Hartsough, Michael J. Vido> ;Pigment Cell & Melanoma Research. 2017 Mar 1
• A multifunctional nanoplatform for imaging, radiotherapy, and the prediction of therapeutic response.
  McQuade C, Al Zaki A, Desai Y, Vido M, Sakhuja T, Cheng Z, Hickey RJ, Joh D, Park SJ, Kao G, Dorsey JF, Tsourkas A> ;Small (Weinheim an der Bergstrasse, Germany). 2014-09-29
• 30 citations
  Multiple components of the spliceosome regulate Mcl1 activity in neuroblastoma
  Theodore W. Laetsch, Xing Ge Liu, Annette Vu, Michael Sliozberg, M. Vido, O.U. Elci, Kelly C. Goldsmith, Michael D. Hogarty> ;Cell Death & Disease. 2014 Feb 20
• Join now to see all